Science at the service of people

Certest Pharma is the new division of Certest Biotec. Our efforts are focused on the development of mRNA vaccines for infectious diseases and cancer immunotherapy.

RNA Synthesis


Available in different Quality Standards:

RUO » Industrial-grade » Customized

Design & RNA Manufacturing

Read more



LNPs & Formulation

Optimized formulations using different lipids, ratios and excipients to enhance RNA delivery and protein expression.

Read more

Optimized lyophilized formulations

with high stability at 4-8 Cº!

Optimized lyophilized formulations

with high stability at 4-8 Cº!

mRNA vaccines: How do they work?

Read more

Expertise and capabilities

Read more


Certest Pharma participates in BIO-EUROPE 2023


The BIO-EUROPE exhibition is one of the most important gathering points for exhibition and partnering in Europe. The event attracts companies from the biotechnological sector, promoting interactions between companies, [...]

Certest Pharma to Visit TIDES Europe


Certest Pharma will be visiting TIDES Europe, a leading industry event at the European level aimed at accelerating the commercialization of therapies by boosting R&D, improving CMC efficiency, and [...]

Certest Pharma Takes Part in CPHI 2023


From October 24th to 26th, in Barcelona, Certest Pharma will participate in the CPHI exhibition, a globally renowned event in the pharmaceutical field where professionals and leaders come together to [...]

A division of Certest Biotec

Go to Top